Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb;238(2):441-451.
doi: 10.1007/s00213-020-05691-w. Epub 2020 Nov 17.

Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine

Affiliations
Randomized Controlled Trial

Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine

Dimitris Repantis et al. Psychopharmacology (Berl). 2021 Feb.

Abstract

Rational: At all times humans have made attempts to improve their cognitive abilities by different means, among others, with the use of stimulants. Widely available stimulants such as caffeine, but also prescription substances such as methylphenidate and modafinil, are being used by healthy individuals to enhance cognitive performance.

Objectives: There is a lack of knowledge on the effects of prescription stimulants when taken by healthy individuals (as compared with patients) and especially on the effects of different substances across different cognitive domains.

Methods: We conducted a pilot study with three arms in which male participants received placebo and one of three stimulants (caffeine, methylphenidate, modafinil) and assessed cognitive performance with a test battery that captures various cognitive domains.

Results: Our study showed some moderate effects of the three stimulants tested. Methylphenidate had positive effects on self-reported fatigue as well as on declarative memory 24 hours after learning; caffeine had a positive effect on sustained attention; there was no significant effect of modafinil in any of the instruments of our test battery. All stimulants were well tolerated, and no trade-off negative effects on other cognitive domains were found.

Conclusions: The few observed significant positive effects of the tested stimulants were domain-specific and of rather low magnitude. The results can inform the use of stimulants for cognitive enhancement purposes as well as direct further research to investigate the effects of stimulants on specific cognitive domains that seem most promising, possibly by using tasks that are more demanding.

Keywords: Caffeine; Cognitive enhancement; Methylphenidate; Modafinil; Neuroenhancement.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Baseline characteristics of the three groups and study design. After screening, 48 subjects were randomized (R) in a double-blind fashion to one of the three arms (MPH: methylphenidate, MOD: modafinil or CAF: caffeine)
Fig. 2
Fig. 2
The amount of words remembered correctly 24 h after learning, per stimulant and their respective placebo condition. The grey dots represent the individual participants’ scores and the white diamond represents the group mean. *, p < .01
Fig. 3
Fig. 3
Subjective fatigue score per stimulant and their respective placebo condition. The grey dots represent the individual participants’ scores and the white diamond represents the group mean. *, p < .01

References

    1. Battleday RM, Brem AK. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. Eur Neuropsychopharmacol. 2015;25:1865–1881. - PubMed
    1. Bäumler G. Lern- und Gedächtnistest, LGT-3. Göttingen: Hogrefe; 1974.
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.
    1. Cahill L. Why sex matters for neuroscience. Nat Rev Neurosci. 2006;7:477–484. - PubMed
    1. Cappelletti S, Daria P, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13:71–88. - PMC - PubMed

Publication types